Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for pharmaceutical industry professionals · Tuesday, September 25, 2018 · 462,991,048 Articles · 3+ Million Readers

Hepatitis C - New Report Explains Symptoms, Causes, Treatment, Screening & Medications 2018-2022

PUNE, INDIA, March 22, 2018 /EINPresswire.com/ -- WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Hepatitis C - Pipeline Review, H1 2018”

Hepatitis C  

Overview

Hepatitis C is a contagious viral infection affecting the liver. It may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea and vomiting the predisposing factors of hepatitis C include dialysis, organ transplant and blood transfusion.

Offspring of an infected mother also has high chances of contracting the disease. Hepatitis C can be controlled with the help of medications or a transplant at an advanced stage.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3066548-hepatitis-c-pipeline-review-h1-2018

 

Major Key Players:

ContraVir Pharmaceuticals Inc

DEKK-TEC Inc

Ennaid Therapeutics LLC

Hoffmann-La Roche Ltd
Galactica Biotech Ltd

AbbVie Inc

Hepatitis C  Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Hepatitis C     - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Hepatitis C    , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Hepatitis C (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 14, 19, 19, 47, 38 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 2, 1, 13 and 20 molecules, respectively.

Hepatitis C pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Hepatitis C - Competitive Analysis

Key players are making innovative developments in Hepatitis C industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Hepatitis C.

The pipeline guide reviews pipeline therapeutics for Hepatitis C by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Hepatitis C therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Hepatitis C therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Hepatitis C.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3066548-hepatitis-c-pipeline-review-h1-2018

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire